High prevalence of HIV, HIV/hepatitis CvVirus coinfection, and risk behaviors among injection drug users in Chennai, India: A cause for concern

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 3, 2008, Pages 327-332

  Solomon, Sunil S ^a,b   Srikrishnan, Aylur K ^b   Mehta, Shruti H ^a   Vasudevan, Conjeevaram K ^b   Murugavel, Kailapuri G ^b   Thamburaj, Easter ^b   Anand, Santhanam ^b   Kumar, M Suresh ^b   Latkin, Carl ^a   Solomon, Suniti ^b   Celentano, David D ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^c NONE   (United States)

Author keywords

Hepatitis B virus; Hepatitis C virus; HIV prevalence; India; Injection drug use; Risk behaviors

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS C ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INDIA; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; COHORT ANALYSIS; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; LONGITUDINAL STUDY; PREVALENCE; PSYCHOLOGICAL ASPECT; SUBSTANCE ABUSE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; PREVALENCE; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 58149175340     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181831e85     Document Type: Article

References (39)

1. Dandona L, Lakshmi V, Kumar GA, et al. Is the HIV burden in India being overestimated? BMC Public Health. 2006;6:308.
2. National AIDS Control Organization (NACO), India. 2.5 Million People in India Living With HIV, According to New Estimates. Available at: http://data.unaids.org/pub/PressRelease/2007/070706-indiapressrelease-en. pdf. Accessed August 10, 2007.
3. UNAIDS. 2006 Report on the Global AIDS Epidemic. Available at: http:// www.unaids.org/en/HIV-data/2006GlobalReport/default.asp. Accessed February 22, 2007.
4. National AIDS Control Organization (NACO), India. HIV Sentinel Surveillance and HIV Estimation, 2006. Available at: http://164.100.12.21/ upload/Documents/HIV%20Sentinel%20Surveillance%20and%20HIV% 20Estimation, %202006.pdf. Accessed January 3, 2008.
5. National AIDS Control Organization (NACO), India. Monthly Updates on AIDS (August 31, 2006). Available at: http://nacoonline.org/facts-reportaug.htm. Accessed March 18, 2007.
6. Gangakhedkar RR, Bentley ME, Divekar AD, et al. Spread of HIV infection in married monogamous women in India. JAMA. 1997;278: 2090-2092.
7. Steinbrook R. HIV in India-a complex epidemic. N Engl J Med. 2007; 356:1089-1093.
8. Dorabjee J, Samson L. A multi-centre rapid assessment of injecting drug use in India. Int J Drug Policy. 2000; 11:99-l 12.
9. Eicher AD, Crofts N, Benjamin S, et al. A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India. AIDS Care. 2000;12:497-504.
10. Panda S, Chatterjee A, Bhattacharjee S, et al. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks. Int J STD AIDS. 1998;9:214-218.
11. Saha MK, Chakrabarti S, Panda S, et al. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their noninjecting wives in Manipur, India. Indian J Med Res. 2000; 111:37-39.
12. Sarkar K, Bal B, Mukherjee R, et al. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, eastern India, bordering Nepal, Bhutan, and Bangladesh. Subst Use Misuse. 2006;41:341-352.
13. Behrens T, Taeger D, Wellmann J, et al. Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med. 2004;43:505-509.
14. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706.
15. McNutt LA, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003; 157:940-943.
16. Robins JM, Greenland S. The role of model selection in causal inference from nonexperimental data. Am J Epidemiol. 1986;123:392-402.
17. National AIDS Control Organization (NACO), India. HIV/AIDS Epidemiological Surveillance & Estimation Report for the Year 2005. Available at: http://nacoonline.org/fnlapil06rprt.pdf. Accessed Febroary22, 2007.
18. Panda S, Kumar MS, Lokabiraman S, et al. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr. 2005;39:9-15.
19. Aceijas C, Friedman SR, Cooper HL, et al. Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect. 2006; 82(Suppl 3):iii10-iii17.
20. AIDS Prevention and Control (APAC), India. HIV Risk Behavior Surveillance Survey in Tamil Nadu Wave X- 2005: Chennai, India. APAC-VHS; 2006.
21. Kumar MS, Mudaliar S, Thyagarajan SP, et al. Rapid assessment and response to injecting drug use in Madras, south India. Int J Drug Policy. 2000;11:83-98.
22. Lumbreras B, Jarrin I, del Amo J, et al. Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART. AIDS. 2006;20:111-116.
23. Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-I, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360:1921-1926.
24. Aceijas C, Oppenheimer E, Stimson GV, et al. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5"). Addiction. 2006;101:1246-1253.
25. Lucas GM, Cheever LW, Chaisson RE. et al. Detrimental effects of continued illicit drug use on the treatment of HIV-I infection. J Acquir Immune Defic Syndr. 2001;27:251-259.
26. Sulkowski MS. Thomas DL, Mehta SH, et al. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology. 2002;35:182-189.
27. Lucas GM. Mullen BA, Weidle PJ, et al. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis. 2006;42:1628-1635.
28. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1:39-44.
29. Rezza G, Titti F, Tempesta E, et al. Needle sharing and other behaviours related to HIV spread among intravenous drug users. AIDS. 1989;3: 247-248.
30. Vlahov D, Munoz A, Anthony JC, et al. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore. Maryland. Am J Epidemiol. 1990; 132:847-856.
31. Akeke VA, Mokgatle M, Oguntibeju OO. Tattooing and risk of transmitting HIV in Quthing prison, Lesotho. Int J STD AIDS. 2007; 18:363-364.
32. Panda S, Chatterjee A, Bhattacharya SK, et al. Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS. 2000; 11 : 468-473.
33. Giovanna F, Bortolotti F, Francesco D. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335-352.
34. Villano SA, Vlahov D, Nelson KE, et al. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 1999;29:908-914.
35. Van Ameijden EJ, Van den Hoek JA, Mientjes GH, et al. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993;9: 255-262.
36. Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City. 19902001. AIDS. 2005;19(Suppl 3):S20-S25.
37. Krai AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidemiol. 2003;157:915-922.
38. Mehta SH, Galai N, Astemborski J, et al. HIV incidence among injection drug users in Baltimore. Maryland (1988-2004). J Acquir Immune Defic Syndr. 2006;43:368-372.
39. Centers for Disease Control and Prevention. Epidemiology of HIV/ AIDS-United States, 1981 -2005. MMWR Morb Mortal Wkly Rep. 2006; 55:589-592.